Moreover, atherogenic dyslipidemia, a condition characterized by elevated levels of triglycerides, small-dense low-density lipoprotein (LDL) particles, apolipoprotein B (apoB) and lipoprotein (a) (Lp(a)) with reduced levels of high-density lipoprotein (HDL) cholesterol, is commonly encountered in patients with T2DM. Here, APOB is linked to metabolic syndrome.